Low-Dose Naltrexone vs Retatrutide

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Low-Dose NaltrexoneRetatrutide
CategoryPharmaceuticalsPharmaceuticals
Standard Dose——
Timing——
Cycle Duration——
Evidence LevelEmergingEmerging (Phase 3 ongoing)
A

Low-Dose Naltrexone

Pharmaceuticals

Mechanism

Transient opioid receptor blockade that may increase endogenous endorphin signaling and modulate immune tone in off-label protocols.

Contraindications

  • Concurrent opioid use
  • Use caution in active liver disease
B

Retatrutide

Pharmaceuticals

Mechanism

Triple incretin agonist (GIP/GLP-1/glucagon receptor). Combines appetite suppression and insulin sensitization of GLP-1 with the thermogenic and lipolytic effects of glucagon receptor activation. Produced the greatest weight loss of any anti-obesity agent in Phase 2 trials (~24% at 48 weeks).

Contraindications

  • Not FDA-approved
  • Presumed similar to GLP-1 class — MTC, pancreatitis, severe GI disease

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →

Related Comparisons

Acarbose vs Low-Dose NaltrexoneAcarbose vs RetatrutideBupropion SR vs Low-Dose NaltrexoneBupropion SR vs RetatrutideCanagliflozin vs Low-Dose NaltrexoneCanagliflozin vs RetatrutideDasatinib + Quercetin (Senolytic Stack) vs Low-Dose NaltrexoneDasatinib + Quercetin (Senolytic Stack) vs Retatrutide
Full Low-Dose Naltrexone profile →Full Retatrutide profile →Check interactions in your full stack →